This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Allergan, Inc.. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Kei Rogers Aoki: Innovator in Immuno-based Assays
Introduction
Kei Rogers Aoki is a notable inventor based in Coto de Caza, California. He has made significant contributions to the field of immunology, particularly in the development of assays related to botulinum toxin.
Latest Patents
Aoki holds a patent for "Immuno-based botulinum toxin serotype A activity assays." This patent discloses SNAP-25 compositions and methods for creating α-SNAP-25 antibodies that bind to specific epitopes. The patent also includes methods for detecting BoNT/A activity and neutralizing α-BoNT/A antibodies.
Career Highlights
Aoki is currently associated with Allergan, Inc., a company known for its innovative approaches in the pharmaceutical industry. His work focuses on advancing the understanding and detection of botulinum toxin, which has important implications for both medical and cosmetic applications.
Collaborations
Some of Aoki's coworkers include Joanne Wang and Patton E Garay, who contribute to the collaborative efforts in research and development at Allergan.
Conclusion
Kei Rogers Aoki's contributions to immunology through his patent on botulinum toxin assays highlight his role as an innovator in the field. His work continues to influence advancements in medical science and therapeutic applications.